CTRI/2019/12/022448尚未招募未知
A Randomized controlled study of alternate day regimen versus daily regimen of oral iron therapy in pregnant women with mild Iron Deficiency Anemia - ADROIT(Alternate Day Regimen in Oral Iron Therapy
CMC vellore0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i.Pregnant women between 12 to 24 weeks
- •ii.Hemoglobin 10.0 to 10.9
- •iii.People consenting for the study
排除标准
- •Exclusion Criteria:
- •a)High risk pregnancies
- •i.Multiple gestations,
- •ii.severe anaemia
- •iii.anaemia with failure
- •iv.risk of preterm delivery
- •b)Medical disorders
- •i.hematological disorders
- •ii.renal disorders
- •iii.chronic infections
- •c)criteria related to iron absorption
- •i.intolerance to oral iron
- •ii.recent blood transfusions in past 30 days
- •iii.Parental therapy
- •iv.Irritable bowel syndrome
- •v.Bariatric surgeries
- •d) people who are not consenting for the study
研究者
相似试验
进行中（未招募）
1 期
A pilot study on the effects of an alternate-day corticosteroid regimen in children with active crohn’s disease - Alternate-day corticosteroid regimen in children with Crohn’s diseaseMedDRA version: 12. Level: LLT Classification code 10013099 Term: Disease CrohnsCrohn's diseaseEUCTR2010-022017-26-GBCentral Manchester University Hospitals Foundation Trust27
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Canceron-small Cell Lung CancerJPRN-UMIN000012098Tokushukai Group Oncology Project45
已完成
2 期
Phase II Study of Alternate-day Administration of S-1 plus Carboplatin in Elderly Patients with Previously Treated Non-small Cell Lung CancerJPRN-UMIN000010989Tokushukai Group Oncology Project32
已完成
2 期
A phase II study of alternate-day administration of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination as first-line treatment in patients with metastatic colorectal cancer.Colorectal cancerJPRN-UMIN000020439Aichi Cancer Center Hospital25
已完成
2 期
Weekly versus three-weekly docetaxel in women with breast cancerCancerISRCTN09184069nited Lincolnshire Hospitals NHS Trust (UK)82